Annual Revenue ($)

Amphastar Pharmaceuticals revenue was $240.18 m in FY, 2017

Quarterly Revenue ($)

FY, 2014FY, 2015FY, 2016FY, 2017
Revenue$210.46 m$251.52 m$255.17 m$240.18 m
Growth19.51%1.45%
Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018
Revenue$49 m$59.71 m$56.89 m$53.85 m$63.87 m$59.37 m$68.03 m$64.22 m$56.67 m$65.19 m$57.92 m$58.39 m$71.04 m$75.54 m
Report incorrect company information

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Amphastar Pharmaceuticals revenue breakdown by business segment: 5.9% from Active Pharmaceutical Ingredients and 94.1% from Finished pharmaceutical products

FY, 2015FY, 2016
Active Pharmaceutical Ingredients26.58 m14.94 m
Finished pharmaceutical products224.94 m240.22 m
Report incorrect company information